Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29927948
Publication Date : //

The route of administration influences the therapeutic index of an anti-proNGF neutralizing mAb for experimental treatment of Diabetic Retinopathy.


Many neurodegenerative retinal diseases are treated with monoclonal antibodies (mAb) delivered by invasive intravitreal injection (IVT). In Diabetic Retinopathy there is a scarcity of effective agents that can be delivered using non-invasive methods, and there are significant challenges in the validation of novel therapeutic targets. ProNGF represents a potential novel target, and IVT administration of a function-blocking anti-proNGF mAb is therapeutic in a mouse model of DR. We therefore compared invasive IVT to less invasive systemic intravenous (IV) and local subconjunctival (SCJ) administration, for therapy of Diabetic Retinopathy. The IV and SCJ routes are safe, afford sustained pharmacokinetics and tissue penetration of anti-proNGF mAb, and result in long-term therapeutic efficacy that blocks retinal inflammation, edema, and neuronal death. SCJ may be a more convenient and less-invasive approach for ophthalmic use and may enable reduced frequency of intervention for the treatment of retinal pathologies.

Authors : Barcelona Pablo F , Galan Alba , Nedev Hinyu , Jian Yifan , Sarunic Marinko V , Saragovi H Uri ,

Related products :

Catalog number Product name Quantity
orb61259 LBH-589 Panobinostat (LBH-589) is an experimental drug developed by Novartis for the treatment of various cancers. For research use only. 500 mg
orb61271 NVP-AUY922 NVP-AUY922 is an experimental drug candidate for the treatment of cancer. For research use only. 5 mg
orb61230 Canertinib Canertinib (CI-1033) is an experimental drug candidate for the treatment of cancer. It is an irreversible tyrosine-kinase inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19 500 mg
orb60271 Lacosamide Lacosamide is a medication developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. For research use only. 10 mg
B1007 Dey_Engley Neutralizing Broth Base USE Used along with Dey_Engley Neutralizing Broth for neutralizing and determining bactericidal activity of quanternary ammonium compounds. Qty per Litre of Medium: 17,5
B1007 Dey-Engley Neutralizing Broth Base USE : Used along with Dey-Engley Neutralizing Broth for neutralizing and determining bactericidal activity of quanternary ammonium compounds. 5x500gm
303-08741 tic and noncataractous), renal proximal tubules in patients with diabetic nephropathy and chronic renal failure, diabetic retina, peripheral nerves of diabetic neuropathy, atherosclerotic lesions of a 20UG
B1006 *Dey_Engley Neutralizing Broth USE For neutralizing and testing antiseptics and disinfectants. Qty per Litre of Medium: 39
B1006 Dey-Engley Neutralizing Broth USE : For neutralizing and testing antiseptics and disinfectants. 5x500gm
DEV201-1-2/02 HIV_PNDmn (Principal Neutralizing Domain), Clone HG_1, Mab anti_, neutralizing & binding 0.2 mg.
DEV201-4-2/02 HIV_PNDmn (Principal Neutralizing Domain), Clone HG_4, Mab anti_, neutralizing & binding 0.2 mg.
DEV201-2-2/02 HIV_PNDmn (Principal Neutralizing Domain), Clone HG_2, Mab anti_, weakly neutralizing, binding 0.2 mg.
TM 716 DEY ENGLEY NEUTRALIZING BROTH (for neutralizing and testing antiseptics and disinfectants) 500 gm
TM 717 DEY ENGLEY NEUTRALIZING BROTH BASE (for neutralizing and determining bactericidal activity of quarternary ammonium compounds) (Store below 8º C) 500 gm
KMMS31 Enema Administration Model 5
KMMS31 Enema Administration Model
202070-86-8 POPG, Na (short route) - 1g
KMMS54 Electronic Enema Administration Simulator
KMMS54 Electronic Enema Administration Simulator 7
KMMS144 Eye Retinopathy Simulator
KMMS144 Eye Retinopathy Simulator 2
SCH-2470-5477 MOUSE ANTI CYTOMEGALOVIRUS 66kDa NEUTRALIZING ANTIGEN, Product Type Monoclonal Antibody, Specificity CYTOMEGALOVIRUS NEUTRALIZING ANTIGEN, Target Species Viral, Host Mouse, Format Purified, Isoty 0.2 mg
2470-5477 MOUSE ANTI CYTOMEGALOVIRUS 66kDa NEUTRALIZING ANTIGEN, Product Type Monoclonal Antibody, Specificity CYTOMEGALOVIRUS NEUTRALIZING ANTIGEN, Target Species Viral, Host Mouse, Format Purified, Isoty 0.2 mg
230776 TAG-DANGER -Ne pas mettre en route-160*75 _ AC Signs;Pack-PK; 10 Pcs Per Pack
Y051704 Anti-proNGF Antibody 50μl


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur